Allovir, Inc. Uncategorized Contracts & Agreements

9 Contracts & Agreements
Recent Contracts
Category
Company
Industry
Jur. Jurisdiction
Filed
Offer Letter, dated December 17, 2024, by and between Brett Hagen and the Registrant, as amended by that certain Offer Letter Amendment, dated April 15, 2025
Allovir, Inc.
Biotechnology
2025
Offer Letter Amendment, dated April 15, 2025, by and between Brett Hagen and Kalaris Therapeutics, Inc
Allovir, Inc.
Biotechnology
2025
Letter Agreement, dated December 31, 2024, by and between Matthew Feinsod and Kalaris Therapeutics, Inc
Allovir, Inc.
Biotechnology
2025
Royalty Agreement, dated as of July 16, 2024, by and between Kalaris Therapeutics, Inc. and Samsara BioCapital L.P
Allovir, Inc.
Biotechnology
CA
2024
Form of Kalaris Support Agreement
Allovir, Inc.
Biotechnology
DE
2024
Form of Lock-Up Agreement
Allovir, Inc.
Biotechnology
2024
Form of AlloVir Support Agreement
Allovir, Inc.
Biotechnology
DE
2024
Description of the Registrants securities registered pursuant to Section 12 of the Securities and Exchange Act of 1934, as amended
Allovir, Inc.
Biotechnology
DE
2021
Sponsored Research Agreement, by and between Baylor College of Medicine and the Registrant, dated as of June 18, 2019, as amended by the Amendment to Sponsored Research Agreement,...
Allovir, Inc.
Biotechnology
TX
2020